COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Ultrasound (US)-Doppler for the Diagnosis of Asymptomatic Deep Vein Thrombosis (DVT) in Gynecologic Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00285038
Recruitment Status : Completed
First Posted : February 1, 2006
Last Update Posted : December 14, 2010
Information provided by:
Rambam Health Care Campus

Brief Summary:
The aim of this study is to determine the prevalence of asymptomatic lower extremity DVT detected by Doppler ultrasound in a selected group of patients suffering from gynecological malignancies.

Condition or disease
Deep Vein Thrombosis

Detailed Description:

The association between malignancy and venous thromboembolism (VTE) is well known. It has been shown that there is a high prevalence of VTE in gynecological malignancies. Early detection of VTE can identify patients who may benefit from anticoagulant therapy and prevent morbidity and mortality.

NO clear guidelines are available for anticoagulant prophylaxis in a selected group of ambulatory gynecological cancer patients. It has been shown, in other selected groups of patients that Ultrasound Doppler can be used in order to diagnose asymptomatic DVT (deep vein thrombosis).

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: US-Doppler for the Diagnosis of Asymptomatic DVT in Gynecologic Cancer Patients
Study Start Date : March 2006
Actual Primary Completion Date : December 2010
Actual Study Completion Date : December 2010

Resource links provided by the National Library of Medicine

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Gynecological Ambulatory cancer patients

Inclusion Criteria:

  • Gynecological cancer patients
  • Ambulatory performance status of 0-2
  • Prior to, or during, chemotherapy and/or radiation

Exclusion Criteria:

  • Before or near surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00285038

Layout table for location information
Rambam Medical Center
Haifa, Israel
Sponsors and Collaborators
Rambam Health Care Campus
Layout table for investigator information
Principal Investigator: Nira Beck-Razi, MD Ministry of Health, Israel
Layout table for additonal information
Responsible Party: Dr Beck-Razi, Rambam Medical Center Identifier: NCT00285038    
Other Study ID Numbers: NIRACTIL
First Posted: February 1, 2006    Key Record Dates
Last Update Posted: December 14, 2010
Last Verified: January 2006
Keywords provided by Rambam Health Care Campus:
Deep vein thrombosis
Gynecological cancer
Additional relevant MeSH terms:
Layout table for MeSH terms
Venous Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases